These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31752131)

  • 21. Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival.
    Doll D; Keller L; Maak M; Boulesteix AL; Siewert JR; Holzmann B; Janssen KP
    Int J Colorectal Dis; 2010 May; 25(5):573-81. PubMed ID: 20162422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
    Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
    Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
    Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.
    Zhang F; Huang W; Sheng M; Liu T
    Tumour Biol; 2015 Mar; 36(3):2041-8. PubMed ID: 25391425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis.
    Olsson L; Hammarström ML; Israelsson A; Lindmark G; Hammarström S
    PLoS One; 2020; 15(2):e0229007. PubMed ID: 32049988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients.
    Lind GE; Guriby M; Ahlquist T; Hussain I; Jeanmougin M; Søreide K; Kørner H; Lothe RA; Nordgård O
    Clin Epigenetics; 2017; 9():97. PubMed ID: 28878843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
    Ichikawa Y; Ishikawa T; Momiyama N; Yamaguchi S; Masui H; Hasegawa S; Chishima T; Takimoto A; Kitamura H; Akitaya T; Hosokawa T; Mitsuhashi M; Shimada H
    Clin Exp Metastasis; 1998 Jan; 16(1):3-8. PubMed ID: 9502072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High CXC Chemokine Ligand 16 (CXCL16) Expression Promotes Proliferation and Metastasis of Lung Cancer via Regulating the NF-κB Pathway.
    Liang K; Liu Y; Eer D; Liu J; Yang F; Hu K
    Med Sci Monit; 2018 Jan; 24():405-411. PubMed ID: 29353287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXC chemokine ligand 16, inversely correlated with CD99 expression in Hodgkin Reed-Sternberg cells, is widely expressed in diverse types of lymphomas.
    Liu F; Zhang Y; Tang H; Zhou X; Wu Z; Tang D; Zhao T
    Oncol Rep; 2013 Aug; 30(2):783-92. PubMed ID: 23743627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
    Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
    Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer.
    Kim MJ; Sun HJ; Song YS; Yoo SK; Kim YA; Seo JS; Park YJ; Cho SW
    Sci Rep; 2019 Sep; 9(1):13288. PubMed ID: 31527616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
    Ren Y; Lv Y; Li T; Jiang Q
    Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Expression of HSPD1, SCUBE3, CXCL14 and Its Relations with the Prognosis in Osteosarcoma.
    Liang W; Yang C; Peng J; Qian Y; Wang Z
    Cell Biochem Biophys; 2015 Dec; 73(3):763-8. PubMed ID: 27259322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer.
    Zajkowska M; Dulewicz M; Kulczyńska-Przybik A; Safiejko K; Juchimiuk M; Konopko M; Kozłowski L; Mroczko B
    Sci Rep; 2023 Oct; 13(1):17688. PubMed ID: 37848726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
    Richardsen E; Ness N; Melbø-Jørgensen C; Johannesen C; Grindstad T; Nordbakken C; Al-Saad S; Andersen S; Dønnem T; Nordby Y; Bremnes RM; Busund LT
    Am J Pathol; 2015 Oct; 185(10):2722-30. PubMed ID: 26272362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients.
    Nordgård O; Oltedal S; Aasprong OG; Søreide JA; Søreide K; Tjensvoll K; Gilje B; Heikkilä R; Guriby M; Lothe RA; Smaaland R; Kørner H
    Ann Surg Oncol; 2012 Nov; 19(12):3719-26. PubMed ID: 22752373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.